Concomitant bone marrow involvement by plasma cell myeloma and primary myelodysplastic syndrome with biclonal complex chromosome anomalies

Nahid M. NanajiBaltimore VA Medical Center, Baltimore, MD, USA

Qing C. ChenDepartment of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA;University of Maryland Marlene and Stuart Greenebaum Cancer Center, Baltimore, MD, USA

Zeba SinghDepartment of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA;University of Maryland Marlene and Stuart Greenebaum Cancer Center, Baltimore, MD, USA

Douglas D. RossBaltimore VA Medical Center, Baltimore, MD, USA;University of Maryland Marlene and Stuart Greenebaum Cancer Center, Baltimore, MD, USA;Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA

Ari H. ElmanUniversity of Maryland Marlene and Stuart Greenebaum Cancer Center, Baltimore, MD, USA;Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA

Ying S. ZouDepartment of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA;University of Maryland Marlene and Stuart Greenebaum Cancer Center, Baltimore, MD, USACorrespondence[email protected]

References

Mailankody S, Pfeiffer RM, Kristinsson SY, et al. Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS). Blood 2011;118: 4086–4092.
PubMed Web of Science ®Google Scholar
Florensa L, Vallespí T, Woessner S, et al. Incidence and characteristics of lymphoid malignancies in untreated myelodysplastic syndromes. Leuk Lymphoma 1996;23:609–612.
PubMed Web of Science ®Google Scholar
Jennane S, Eddou H, Mahtat el M, et al. Association between multiple myeloma and acute myeloid leukemia secondary to myelodysplastic syndrome. J Ann Biol Clin (Paris) 2013;71:581–584.
PubMed Web of Science ®Google Scholar
Ortega M, Mallo M, Solé F, et al. 5q- syndrome and multiple myeloma diagnosed simultaneously and successful treated with lenalidomide. Leuk Res 2013;37:1248–1250.
PubMed Web of Science ®Google Scholar
O’Keefe C, McDevitt MA, Maciejewski JP. Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies. Blood 2010;115:2731–2739.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Concomitant bone marrow involvement by plasma cell myeloma and primary myelodysplastic syndrome with biclonal complex chromosome anomalies

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Concomitant bone marrow involvement by plasma cell myeloma and primary myelodysplastic syndrome with biclonal complex chromosome anomalies

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date